Review
Rev Diabet Stud,
2012,
9(1):23-35 |
DOI 10.1900/RDS.2012.9.23 |
The Diabetic Lung - A New Target Organ?
Dario Pitocco1,2, Leonello Fuso2,3, Emanuele G. Conte3, Francesco Zaccardi1, Carola Condoluci3, Giuseppe Scavone1, Raffaele Antonelli Incalzi4, Giovanni Ghirlanda1
1Diabetes Care Unit, Catholic University of Rome, Italy
2Equally contributed to the paper
3Respiratory Disease Unit, Catholic University of Rome, Italy
4Geriatric Medicine, University Campus Bio-Medico, Rome, Italy
Address correspondence to: Dario Pitocco, MD, Servizio di Diabetologia, Policlinico A. Gemelli, L.go A. Gemelli 1, 00168 Roma, Italy, e-mail: dario.pitocco@rm.unicatt.it
Manuscript submitted April 11, 2012; resubmitted April 25, 2012; accepted May 4, 2012.
Keywords: diabetic lung, diabetes, hyperglycemia, respiratory dysfunction, microvascular reserve, ventilatory pump
Abstract
Several abnormalities of the respiratory function have been reported in patients with type 1 and type 2 diabetes. These abnormalities concern lung volume, pulmonary diffusing capacity, control of ventilation, bronchomotor tone, and neuroadrenergic bronchial innervation. Many hypotheses have emerged, and characteristic histological changes have been described in the "diabetic lung", which could explain this abnormal respiratory function. Given the specific abnormalities in diabetic patients, the lung could thus be considered as a target organ in diabetes. Although the practical implications of these functional changes are mild, the presence of an associated acute or chronic pulmonary and/or cardiac disease could determine severe respiratory derangements in diabetic patients. Another clinical consequence of the pulmonary involvement in diabetes is the accelerated decline in respiratory function. The rate of decline in respiratory function in diabetics has been found to be two-to-three times faster than in normal non-smoking subjects, as reported in longitudinal studies. This finding, together with the presence of anatomical and biological changes similar to those described in the aging lung, indicates that the "diabetic lung" could even be considered a model of accelerated aging. This review describes and analyses the current insight into the relationship of diabetes and lung disease, and suggests intensifying research into the lung as a possible target organ in diabetes.
Fulltext:
HTML
, PDF
(153KB)
This article has been cited by other articles:
|
Thorax Computed Tomography Findings in Patients with Erectile Dysfunction
Resorlu M, Arslan M, Karatag O, Adam G
J Clin Imag Sci 2017. 7:25
|
|
|
Diabetes and the lung
Wilkens H, Leser D
Pneumol 2017. 14(4):219-227
|
|
|
The impact of lungs from diabetic donors on lung transplant recipients
Ambur V, Taghavi S, Jayarajan S, Kadakia S, Zhao H, Gomez-Abraham J, Toyoda Y
Eur J Cardiothorac Surg 2017. 51(2):285-290
|
|
|
Potential Biochemical Mechanisms of Lung Injury in Diabetes
Zheng H, Wu J, Jin Z, Yan LJ
Aging Dis 2017. 8(1):7-16
|
|
|
Redox imbalance and mitochondrial abnormalities in the diabetic lung
Wu J, Jin Z, Yan LJ
Redox Biol 2016. In press
|
|
|
ALLOXAN - DIABETES CAUSES OXIDATIVE IMBALANCE AND MORPHOLOGICAL, MORPHOMETRIC AND ULTRASTRUCTURAL CHANGES IN RAT LUNGS
Suarez OA, Lucchesi AN, Cataneo AJ, Spadella CT
Eur J Pharm Med Res 2016. 3(12):1-10
|
|
|
Lung function in patients with diabetes mellitus
Fontaine-Delaruelle C, Viart-Ferber C, Luyton C, Couraud S
Rev Pneumol Clin 2016. 72(1):10-16
|
|
|
Pulmonary Function Test Profile in 8-18 Years Old Patients with Type 1 Diabetes Mellitus
Irlisnia I, Supriyatno B, Tridjadja B, Windiastuti E
Sari Pediatri 2015. 17(4):241-248
|
|
|
The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus
Cayir A, Ugan RA, Albayrak A, Kose D, Akpinar E, Cayir Y, Atmaca HT, Bayraktutan Z, Kara M
J Endocrinol Invest 2015. 38(9):987-998
|
|
|
High-mobility group box 1 enhances the inflammatory process in diabetic lung
Boteanu RM, Uyy E, Suica VI, Antohe F
Arch Biochem Biophys 2015. 583:55-64
|
|
|
STUDY OF PULMONARY FUNCTION TESTS IN TYPE 2 DIABETI C PATIENTS: CORRELATION WITH GLYCEMIC STATUS
Kulkarni GV, Surdi AD
Int J Pharm Bio Sci 2015. 6(4):138-145
|
|
|
Cystic fibrosis related diabetes
O'Shea D, O'Connell J
Curr Diab Rep 2014. 14(8):511
|
|
|
Selective therapeutic effect of cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats
Han Y, Jung HW, Park YK
Am J Chin Med 2014. 42(5):1169-1182
|
|
|
Type 2 Diabetes Mellitus: The Concerned Complications and Target Organs
Kumar A, Bharti SK, Kumar A
Apollo Med 2014. 11(3):161-166
|
|
|
Effect of oral vanadium supplementation on oxidative stress factors in the lung tissue of diabetic rats
Yilmaz-Ozden T, Kurt-Sirin O, Tunali S, Akev N, Can A, Yanardag R
Trace Elements Electrol 2014. 31(2):48-52
|
|
|
Effects of vitamin E on pathological changes induced by diabetes in rat lungs
Alireza S, Leila N, Siamak S, Mohammad-Hasan KA, Behrouz I
Respir Physiol Neurobiol 2013. 185(3):593-599
|
|
|
Is lung a target of diabetic injury? The novel pro and cons evidence
Popov D
Proc Rom Acad 2013. 15(2):99-104
|
|
|